Sort   by:  
 Page size 
UnknownA phase I study of sunitinib plus capecitabine in patients with advanced solid tumors.
Not available
S-EPMC2988641 | biostudies-literature
UnknownA phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia.
Not available
S-EPMC4576993 | biostudies-literature
UnknownIbrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.
Not available
S-EPMC10082299 | biostudies-literature
UnknownMC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.
Not available
S-EPMC7479262 | biostudies-literature
UnknownSynthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.
Not available
S-EPMC4944207 | biostudies-literature
UnknownIdentifying novel mechanisms of biallelic TP53 loss refines poor outcome for patients with multiple myeloma.
Not available
S-EPMC10495448 | biostudies-literature
UnknownGenetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival.
Not available
S-EPMC5272783 | biostudies-literature
UnknownAssociation of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project.
Not available
S-EPMC5317175 | biostudies-literature
UnknownGenetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.
Not available
S-EPMC5275751 | biostudies-literature
UnknownGenetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival.
Not available
S-EPMC5282969 | biostudies-literature
Sort   by:  
 Page size